Global Automated Liquid Handling System Market Size

Automated Liquid Handling System Market Analysis

The Automated Liquid Handling System Market is expected to grow at the registered CAGR of 6.8% during the forecast period, 2022-2027.

The pandemic has impacted every aspect of the diagnostics, pharmaceutical, and medical industry, including the Automated Liquid Handling System market. The rising pressure to increase the R&D and testing volume led to the high adoption of automated liquid handling systems as these systems help in handling large volumes of PCR tests with accurate clinical outcomes. Market players made various attempts to provide the automated workflows to biopharmaceutical firms. For instance, in 2021, Thermo Fisher leveraged Tecan's liquid handling solutions for laboratory automation to enable scaled-up COVID-19 testing globally. Similarly, in March 2020, Hamilton Company announced multiple automation-related initiatives to aid healthcare workers and researchers. Two new automated assay ready workstations, based on the Company's Microlab STARlet liquid handling workstation, facilitate rapid, high-throughput diagnostic and research-based testing of SARS-CoV-2, the coronavirus that causes the novel COVID-19.

Flexibility and adaptability of lab automation systems and technological advancements in automated liquid handling systems are some of the factors driving this market's expansion. According to the study titled "Lab Automation in Clinical Diagnostics" published in the AZO Network in February 2022, has calculated that between 10 and 20 % of United States diagnoses are incorrect, which could result in 40,000-80,000 deaths annually due to diagnostic mistakes. By lowering the need for trained staff, automation systems can also lower the long-term costs of running various laboratory processes. Therefore, to reduce error and maximise the advantages of automation in clinical laboratories, automation has been widely used to increase accuracy and reduce costs.

Furthermore, increasing clinical trials coupled with rising number of research studies in biopharmaceutical industry will stimulate the automated liquid handling systems market progression in coming future. For instance, as per ClinicalTrials.gov currently 421,258 clinical studies are going on with locations in all 50 States and in 221 countries as of July 2022. Thus, rising number of clinical trials to develop novel treatments afor chronic diseases highlights the potential requirement for automated liquid handling systems used in clinical research

Major participants are adopting strategic formulations such as forward integration, new product development, geographical expansion and research collaborations in order to garner maximum revenue share and promote company growth. For instance, in April 2022, Global clinical diagnostics company Novacyt introduced a new automated liquid handling system to meet growing demand for no manual pipetting in COVID-19 PCR testing. The CO-Prep Automated Liquid Handling System is for use with the PROmate COVID-19 assay workflows, designed to support busy laboratories and private healthcare providers to perform efficient COVID-19 testing. Additionally, in April 2020, Thermo Fischer Scientific and Hamilton Co. launched the ID NIMBUS Presto workstation by integrating Hamilton's liquid handling expertise and Thermo Fisher Scientific's nucleic acid purification strategy. This strategic collaboration helped the company to gain competitive edge and bolster its industrial position.

Thus, all aforementioned factors expected to boost the market growth over the forecast period. However, slower adoption rates in small- and medium-sized organizations restraint the market growth.